Causaly

Causaly is the agentic AI platform purpose-built for life sciences R&D, combining a biomedical knowledge graph, AI agents, and scientific reasoning to help pharmaceutical and biotech companies accelerate drug discovery and development through evidence-based decision velocity. Founded in 2018 in London, Causaly has grown into a defining brand in the AI for life sciences category with substantial enterprise customer adoption, recent partnerships including Pulitzer Prize-winning author Dr. Siddhartha Mukherjee for thought leadership content on the new pace of drug discovery, and substantial venture funding from leading biotech and AI investors. Pricing is enterprise-only with no public self-serve tier. Public benchmarks place Causaly deployments in the $200,000-$2,000,000+ per year range depending on company size, R&D scope, and module selection. The platform is purpose-built for pharmaceutical and biotech R&D operations rather than general-purpose research, which means pricing reflects enterprise life sciences market positioning competitive with other specialized biomedical tools. Implementation typically runs 8-16 weeks including discovery, biomedical knowledge graph configuration, AI agent setup for specific R&D use cases, integration with internal scientific tools, and R&D team rollout. Causaly's differentiation versus general-purpose AI research agents (Gemini Deep Research, ChatGPT Deep Research) and broader life sciences AI tools (BenchSci, Scite.ai) is the biomedical knowledge graph foundation combined with agentic AI for R&D-specific use cases: rather than positioning as a general AI research tool (Gemini pattern) or citation platform (Scite.ai pattern), Causaly is built around a proprietary biomedical knowledge graph that captures relationships between genes, proteins, diseases, drugs, and biological mechanisms — letting AI agents reason about biology, generate hypotheses, and support R&D decisions with evidence-based intelligence that horizontal tools cannot provide. Causaly capabilities include biomedical knowledge graph search, AI agents for R&D workflows (target identification, drug repositioning, mechanism investigation, safety assessment), evidence synthesis from scientific literature, integration with internal pharmaceutical databases, and enterprise security for proprietary R&D data. The platform serves pharmaceutical companies, biotech firms, and research-intensive life sciences organizations globally. Causaly operates under SOC 2 Type II, ISO 27001, GDPR, HIPAA, and broader life sciences regulatory compliance.